VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) was down 11.8% during trading on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. Approximately 222,895 shares changed hands during trading, a decline of 24% from the average daily volume of 293,391 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Down 9.1 %
The stock has a market capitalization of C$24.33 million, a P/E ratio of -4.63 and a beta of 0.39. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The stock’s fifty day moving average is C$0.11 and its two-hundred day moving average is C$0.13.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- What is the Nasdaq? Complete Overview with History
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
